Prof. Dr. med. Jörg Müller

Facharzt für Neurologie
Vivantes Klinikum Spandau


  Kontakt:
Neurologie Neue Bergstraße 6 13585 Berlin
	   	   

Professor Dr. Joerg Mueller Medical Director Vivantes Hospital Berlin Spandau Neue Bergstrasse 6 13585 Berlin Biography Professor Mueller is Director of the Department of Neurology and Medical Director of Vivantes Hospital Berlin Spandau, Academic Teaching Hospital of the Charité Berlin. He held a residency in Neurosurgery at the Charité, Humboldt University, Berlin and in Neurology at the Medical University Innsbruck, Austria. He has been an instructor and attending neurologist, teaching many residents and medical students in Austria and Germany. In 2004, he accepted his Professorship at the Medical University Innsbruck and in December 2008, Professor Mueller was appointed Director of the Department of Neurology, Academic Hospital Berlin Spandau, Germany. In 2017, he was also appointed Medical Director of the Hospital. Professor Mueller is an international renowned expert in the field of Parkinson`s disease, dystonia and tremor syndromes. His primary research interests include Parkinson`s disease, dystonia, tremor syndromes and Botulinum Toxin Therapy as well as DBS in movement disorders. Professor Mueller has written extensively on these subjects and has authored more than 100 original publications in peer-reviewed journals and several textbook contributions. He is a member of many national and international professional, educational, and research societies including the International Movement Disorder Society, the German and Austrian Societies of Clinical Neurophysiology and is a board member of the Austrian Botulinum Toxin and the German DBS Society. Since 2017, Prof. Mueller also serves as president of the German Botulinum Toxin Society. He also serves as reviewer of several international scientific journals

Neutralisierende Antikörper in der Botulinum Neurotoxin-Therapie
Diese Fortbildung ist mit 4 CME-Punkte zertifiziert
Mit 4 CME-Punkten zertifiziert bei der BLÄK (Bayerische Landesärztekammer) für die Fachgruppe Arzt
Diese Fortbildung ist für Sie kostenfrei

CME-Beschreibung:

Die Anwendung von körperfremden Pharmaproteinen kann mit der Entwicklung neutralisierender Antikörper einhergehen und damit zum Therapieverlust einer oft lebenslang benötigten Behandlungsoption führen.

  Referent:

Facharzt für Neurologie - Vivantes Klinikum Spandau